Nalorphine dinicotinate
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| (5α,6α)-17-allyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diyl dinicotinate | |
| Clinical data | |
| Legal status | ℞ Prescription only |
| Identifiers | |
| CAS number | 3194-25-0 |
| ATC code | None |
| PubChem | CID 3083791 |
| ChemSpider | 2340945 |
| Chemical data | |
| Formula | C31H27N3O5 |
| Mol. mass | 521.563 g/mol |
| SMILES
| |
| |
Nalorphine dinicotinate (Nimelan), or N-allylnormorphine dinicotinate, also known as niconalorphine, is a semisynthetic, mixed opioid agonist-antagonist used as a narcotic antagonist.[1][2]
It is the 3,6-dinicotinate ester of nalorphine.
See also
References
- ↑ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1395. ISBN 978-0-412-46630-4. Retrieved 11 May 2012.
- ↑ Lemuel B. Wingard (1991). Human pharmacology: molecular-to-clinical. Mosby-Year Book. ISBN 978-0-8016-5632-3. Retrieved 11 May 2012.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.